Skip to main content
Cardiolucent

Service

Cardiac Arrhythmia Management

Longitudinal management of arrhythmia — medical therapy, anticoagulation strategy, lifestyle optimization, and coordinated, expedited access to electrophysiology when ablation or device therapy becomes the right step.

What this covers

The management side of arrhythmia — after the diagnosis is made.

Once an arrhythmia has been diagnosed, the long arc of care begins. Atrial fibrillation needs ongoing rate-versus-rhythm decisions, anticoagulation strategy based on stroke risk, and recurrent reassessment as treatment effects emerge. Premature beats need to be characterized as benign or burden-significant. Brady- and tachy-arrhythmias need periodic re-evaluation as symptoms and physiology shift over time. Most patients don't need a procedure — but the ones who do need to get there quickly and without friction.

This service is the medical-management counterpart to Assessment of Arrhythmia: where assessment focuses on diagnosis and initial work-up, management is the longitudinal relationship that comes after.

Medical optimization, lifestyle, and serial reassessment.

Most arrhythmia management is medical, not procedural. Cardiolucent visits cover: rate-control vs. rhythm-control decisions, anticoagulation strategy calibrated to your specific stroke and bleeding risk profile, treatment of the contributing conditions that drive arrhythmia (sleep apnea, hypertension, thyroid dysfunction, alcohol, electrolyte status, deconditioning), serial monitor interpretation to track treatment response, and structured de-prescribing when the data supports it. Wearable data (Apple Watch, KardiaMobile) is read alongside formal monitoring — both have their place.

Expedited, coordinated access to electrophysiology.

When ablation, cardioversion, or device therapy (pacemaker, defibrillator, loop recorder) becomes the right next step, Dr. Kedan refers directly to a trusted cardiac electrophysiologist in Los Angeles — with your imaging, monitor data, and clinical context packaged for the receiving team. The goal is no slipped timelines: members get expedited consultation, pre-procedure optimization handled in our office, communication with the EP physician peri-procedure, and post-procedure follow-up coordinated through Cardiolucent.

Common Questions

Frequently Asked Questions

How is this different from Assessment of Arrhythmia?
Assessment is the upstream work — figuring out what the arrhythmia is and how often it happens. Management is everything that comes after: ongoing medication, anticoagulation decisions, lifestyle work, serial monitoring, and getting you to an interventional procedure when one becomes appropriate. Most patients move from one to the other; both happen at Cardiolucent, with Dr. Kedan as the consistent clinician.
Do you perform ablations?
No. Catheter ablation is performed in an electrophysiology lab by a cardiac electrophysiologist. Dr. Kedan does the upstream medical management and coordinates the referral when the data supports proceeding, then resumes longitudinal care after the procedure.
I'm in atrial fibrillation — should I just go straight to ablation?
Not necessarily. Many patients do excellent on optimized medical therapy alone. Others benefit from earlier ablation — recent trial data has shifted that threshold for selected patients. The decision is individualized to your symptom burden, AFib duration and pattern, structural-heart status, anticoagulation tolerance, and goals. Dr. Kedan walks through the tradeoffs and coordinates with electrophysiology when the answer is intervention.
How is anticoagulation decided?
Stroke-prevention anticoagulation in atrial fibrillation is calibrated using established risk scores (CHA2DS2-VASc for stroke, HAS-BLED for bleeding) alongside the specifics of your medical history. For most patients with AFib and significant stroke risk, a direct oral anticoagulant (DOAC) is the standard. The decision is reviewed at every visit — risk profiles shift, and so does the right answer.
Will I need a wearable monitor on an ongoing basis?
Depends on what we're tracking. Some patients wear a 14-day patch periodically to assess AFib burden or rhythm-control efficacy. Some use consumer wearables (Apple Watch / KardiaMobile) as their primary surveillance, with formal monitoring layered in periodically. Some need an implantable loop recorder for rare events. The right tool fits the question — Dr. Kedan picks deliberately rather than ordering the same monitor for everyone.

Explore

Related Services

Talk to Dr. Kedan about your situation.

Schedule a consultation at Cardiolucent in Beverly Hills.
Schedule a Consultation

Medical Disclaimer

The information on this site is for general educational purposes only and is not medical advice, diagnosis, or treatment. Reading this site does not create a doctor–patient relationship. Always consult a qualified healthcare professional for personal guidance. If this is an emergency, call 911. Mentions of medications, devices, or procedures are informational and not endorsements. Full medical disclaimer.

†Some listed indications involve investigational/off-label use. Learn more.